Pubblicazioni scientifiche sui diagnostici non invasivi BioPredictive

Studi sottoposti a revisione paritaria che convalidano i diagnostici ematici BioPredictive per le malattie del fegato — dalle coorti di sviluppo pionieristiche alle meta-analisi a lungo termine.

3/435 Risultati per
“granularity”

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

Poynard T et al. · Diagnostics (Basel) · 2025 Punteggio 100

**Background/Objectives:** Bariatric surgery (BS), drugs approved for type-2-diabetes (T2D…

FibroTest-T2D Metabolic
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Poynard T et al. · Biomedicines · 2025 Punteggio 84

**Background:** The current definition of metabolic dysfunction-associated steatotic liver disease (MASLD…

FibroTest NashTest-2 SteatoTest-2 Metabolic
Noninvasive Assessment of Liver Fibrosis. Key publication Review

Castera L et al. · N Engl J Med · 2025 Punteggio 67

FibroTest Metabolic

Mostra l'elenco completo dei risultati. La pagina è renderizzata sul server e non è paginata.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Noninvasive Assessment of Liver Fibrosis. Key publication Review